• Citer

Expression of immunologic genes in triple-negative and HER2-positive breast cancer in the neoadjuvant GEPARSIXTO trial: Prediction of response to carboplatin-based chemotherapy

par Denkert, Carsten;Von Minckwitz, Gunter;Brase, Jan JC;Darb-Esfahani, Silvia;Gade, S;;Kronenwett, Ralf;Salat, Christoph;Loi, Sherene ;Schem, C.;Sotiriou, Christos ; [et al.]
Référence ASCO Annual Meeting(May 30-June 3, 2014: Chicago, USA), J Clin Oncol, Vol. 32:5s
Publication Publié, 2014

Abstract de conférence

• Détails
• Contenu

Résumé :

Abstract 510